These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3381943)

  • 1. Ascorbic acid and dopamine activity.
    Kanofsky JD; Kay SR; Lindenmayer JP; Seifter E
    Am J Psychiatry; 1988 Jul; 145(7):904-5. PubMed ID: 3381943
    [No Abstract]   [Full Text] [Related]  

  • 2. Semidehydroascorbate as a product of the enzymic conversion of dopamine to norepinephrine. Coupling of semidehydroascorbate reductase to dopamine-beta-hydroxylase.
    Diliberto EJ; Allen PL
    Mol Pharmacol; 1980 May; 17(3):421-6. PubMed ID: 7393218
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of imipramine treatment on plasma dopamine beta-hydroxylase activity in chronic mild stress in rats.
    Grabowska M; Schlegel-Zawadzka M; Papp M; Nowak G
    Pol J Pharmacol; 2004; 56(6):825-9. PubMed ID: 15662096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high ascorbic acid intake on the metabolism of catecholamines in the rat.
    Behrens WA; Madère R
    J Nutr; 1980 Apr; 110(4):720-4. PubMed ID: 7365540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of haloperidol by ascorbic acid in phencyclidine intoxication.
    Giannini AJ; Loiselle RH; DiMarzio LR; Giannini MC
    Am J Psychiatry; 1987 Sep; 144(9):1207-9. PubMed ID: 3631319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid efficiently enhances neuronal synthesis of norepinephrine from dopamine.
    May JM; Qu ZC; Nazarewicz R; Dikalov S
    Brain Res Bull; 2013 Jan; 90():35-42. PubMed ID: 23022576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-beta-hydroxylase.
    Kaufman S
    J Psychiatr Res; 1974; 11():303-16. PubMed ID: 4461800
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
    Wimalasena K; Dharmasena S; Wimalasena DS
    Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid: the concept of optimum requirements.
    Levine M; Hartzell W
    Ann N Y Acad Sci; 1987; 498():424-44. PubMed ID: 3304070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stein and Wise theory of schizophrenia: a possible mechanism for 6-hydroxydopamine formation in vivo.
    Adams RN
    Behav Biol; 1972 Dec; 7(6):861-6. PubMed ID: 4655404
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disulfiram (anticol) psychoses].
    Gyuris J; Szalay A
    Orv Hetil; 1986 Oct; 127(40):2435-7. PubMed ID: 3537906
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurements of noradrenaline overflow and dopamine-beta-hydroxylase activity in superfused preparations [proceedings].
    Fadloun Z; Leach GD
    Br J Pharmacol; 1978 Nov; 64(3):464P. PubMed ID: 719305
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA.
    Sershen H; Debler EA; Lajtha A
    J Neurosci Res; 1987; 17(3):298-301. PubMed ID: 3496464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acute incidents in drug addiction].
    Barth L
    Nervenarzt; 1972 May; 43(5):266-7. PubMed ID: 4559590
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of in vivo dopamine- -hydroxylase activity in rat brain.
    Stolk JM
    J Pharmacol Exp Ther; 1973 Aug; 186(2):230-40. PubMed ID: 4719778
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects.
    Heikkila RE; Cabbat FS; Manzino L
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The catecholaminergic system of the quail brain: immunocytochemical studies of dopamine beta-hydroxylase and tyrosine hydroxylase.
    Bailhache T; Balthazart J
    J Comp Neurol; 1993 Mar; 329(2):230-56. PubMed ID: 8095939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylethanolamine-N-methyltransferase activity determines the epinephrine concentration of pheochromocytomas.
    Feldman JM
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):389-98. PubMed ID: 7323441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of catecholamines in the prolactin release induced by salsolinol.
    Székács D; Bodnár I; Vizi ES; Nagy GM; Fekete MI
    Neurochem Int; 2007 Oct; 51(5):319-22. PubMed ID: 17764787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.